Macrophages are a pivotal component of the immune system, known for their versatility and essential roles in development, ...

The in vivo cell therapy seed Carisma Therapeutics planted with Moderna in 2022 is starting to sprout. | The in vivo cell ...

Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...

Fructose, the most common food sweetener, is widely used in processed sugary beverages, candies, and baked goods. Excessive ...

Background Peritoneal metastasis is the most common metastasis pattern of gastric cancer. Patients with gastric cancer ...

Corvus Pharmaceuticals Inc. (CRVS) announced new data highlighting the potential of ciforadenant, the Company's adenosine A2A ...

This will involve moving its first cancer drug into clinical trials, and starting work on projects involving macrophages and the role they play in inflammatory diseases. Bregenholt told ...

But what a macrophage in the lung adapts to is different from what a macrophage in the uterus or gut adapts to.” “When you design immunotherapy for colorectal cancer, for example, you can't just ...

Pheast Therapeutics (“Pheast”), a biotech developing novel macrophage checkpoint therapies to defy cancer, today announced the presentation of new preclinical data for PHST001, an anti-CD24 antibody ...

USC researchers have found that targeting CD47, a protein enabling cancer to evade immune cells, could enhance colorectal ...